Amgen (AMGN) Long-Term Debt Repayments (2016 - 2025)
Historic Long-Term Debt Repayments for Amgen (AMGN) over the last 15 years, with Q3 2025 value amounting to $1.5 billion.
- Amgen's Long-Term Debt Repayments fell 3181.82% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 billion, marking a year-over-year increase of 3888.89%. This contributed to the annual value of $3.6 billion for FY2024, which is 14759.28% up from last year.
- As of Q3 2025, Amgen's Long-Term Debt Repayments stood at $1.5 billion, which was down 3181.82% from $1.0 billion recorded in Q2 2025.
- Amgen's 5-year Long-Term Debt Repayments high stood at $4.2 billion for Q4 2021, and its period low was $704.0 million during Q1 2023.
- Moreover, its 4-year median value for Long-Term Debt Repayments was $1.5 billion (2024), whereas its average is $1.8 billion.
- In the last 5 years, Amgen's Long-Term Debt Repayments surged by 19333.33% in 2024 and then plummeted by 3181.82% in 2025.
- Quarter analysis of 4 years shows Amgen's Long-Term Debt Repayments stood at $4.2 billion in 2021, then tumbled by 81.93% to $750.0 million in 2023, then surged by 193.33% to $2.2 billion in 2024, then crashed by 31.82% to $1.5 billion in 2025.
- Its last three reported values are $1.5 billion in Q3 2025, $1.0 billion for Q2 2025, and $2.5 billion during Q1 2025.